GlassScriptPhysician profile
Brandon Sumpio
NPI 1740778356
$3,023.49
in general payments reported to CMS, 2019-2025
9 companies · $2,477 in 2025
The $2,477 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.80 · 2021: $177 · 2023: $69.12 · 2024: $286 · 2025: $2,477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,429 · Travel and Lodging: $1,403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,428.53 |
| Travel and Lodging | $1,403.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,525.09 | 2025 | General - Therapies |
| Stryker Corporation | $342.71 | 2025 | Limflow System, Flowtriever, Clottriever Bold Catheter |
| Bolton Medical INC | $342.18 | 2023-2025 | Treo Abdominal Stent-Graft System |
| Polynovo North America LLC | $231.16 | 2024-2025 | Novosorb Btm |
| Bard Peripheral Vascular, INC. | $177.10 | 2021 | |
| Angiodynamics, INC. | $171.30 | 2025 | Auryon Laser System 100-120 Vac |
| Silk Road Medical, INC. | $112.54 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| W. L. Gore & Associates, INC. | $106.61 | 2025 | Gore Tag Thoracic Branch Endoprosthesis |
| Braintree Laboratories, INC. | $14.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Sumpio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.